91 related articles for article (PubMed ID: 20440038)
1. Management of restenosis in drug-eluting stents: still a challenge!
Gupta M; Kadakia J; Budoff MJ
J Invasive Cardiol; 2010 May; 22(5):220-1. PubMed ID: 20440038
[No Abstract] [Full Text] [Related]
2. [Drug-eluting stents in multivessel coronary artery disease: Was one of the important fortresses of surgery conquered?].
Okmen AS; Okmen E
Anadolu Kardiyol Derg; 2009 Aug; 9(4):325-30. PubMed ID: 19666436
[TBL] [Abstract][Full Text] [Related]
3. Recent progress in percutaneous coronary intervention: evolution of the drug-eluting stents, focus on the XIENCE V drug-eluting stent.
Doostzadeh J; Clark LN; Bezenek S; Pierson W; Sood PR; Sudhir K
Coron Artery Dis; 2010 Jan; 21(1):46-56. PubMed ID: 19952925
[TBL] [Abstract][Full Text] [Related]
4. Studies of drug-eluting stents: to each his own?
Mauri L; Normand SL
Circulation; 2008 Apr; 117(16):2047-50. PubMed ID: 18427142
[No Abstract] [Full Text] [Related]
5. Secrets of success in unprotected left main intervention: patient and lesion selection.
Sharma M; Yeghiazarians Y
J Invasive Cardiol; 2007 Sep; 19(9):388-9. PubMed ID: 17827508
[No Abstract] [Full Text] [Related]
6. Clinical outcomes following percutaneous coronary intervention with drug-eluting vs. bare-metal stents in dialysis patients.
Halkin A; Selzer F; Marroquin O; Laskey W; Detre K; Cohen H
J Invasive Cardiol; 2006 Dec; 18(12):577-83. PubMed ID: 17197706
[TBL] [Abstract][Full Text] [Related]
7. Restenosis related to percutaneous coronary intervention has been solved?
Kivelä A; Hartikainen J
Ann Med; 2006; 38(3):173-87. PubMed ID: 16720432
[TBL] [Abstract][Full Text] [Related]
8. Predictors of early discontinuation of dual-antiplatelet therapy: room for improvement.
Jarvie JL; Foody JM
Circulation; 2010 Sep; 122(10):946-8. PubMed ID: 20733094
[No Abstract] [Full Text] [Related]
9. Cardiology patient page. Drug-eluting stents.
Maisel WH; Laskey WK
Circulation; 2007 May; 115(17):e426-7. PubMed ID: 17470700
[No Abstract] [Full Text] [Related]
10. Coronary artery restenosis: a paradigm of current treatment approaches.
Kiernan TJ; Kiernan GD; Yan BD
Minerva Cardioangiol; 2009 Feb; 57(1):77-94. PubMed ID: 19202520
[TBL] [Abstract][Full Text] [Related]
11. Recurrent restenosis after implantation of sirolimus-eluting stents in aorto-ostial lesions: successful treatment with polytetrafluoroethylene-covered stents.
Gagnor A; Varbella F; Rubartelli P; Luceri S; Conte MR
J Cardiovasc Med (Hagerstown); 2008 Feb; 9(2):201-4. PubMed ID: 18192816
[TBL] [Abstract][Full Text] [Related]
12. High residual platelet reactivity after clopidogrel loading and long-term clinical outcome after drug-eluting stenting for unprotected left main coronary disease.
Migliorini A; Valenti R; Marcucci R; Parodi G; Giuliani G; Buonamici P; Cerisano G; Carrabba N; Gensini GF; Abbate R; Antoniucci D
Circulation; 2009 Dec; 120(22):2214-21. PubMed ID: 19917884
[TBL] [Abstract][Full Text] [Related]
13. Percutaneous stenting of the left main with drug eluting stents for in-stent restenosis: immediate- and long-term results.
Mixon T; Fitzsimmons P
J Invasive Cardiol; 2006 Jun; 18(6):E166-8. PubMed ID: 16775892
[No Abstract] [Full Text] [Related]
14. Bifurcation coronary artery disease: current techniques and future directions (part 2).
Rizik DG; Klassen KJ; Hermiller JB
J Invasive Cardiol; 2008 Mar; 20(3):135-41. PubMed ID: 18316830
[No Abstract] [Full Text] [Related]
15. Applying drug-eluting stents in clinical practice.
King SB
Am J Cardiol; 2007 Sep; 100(5A):25K-31K. PubMed ID: 17719350
[TBL] [Abstract][Full Text] [Related]
16. Peeling-off labels mounting evidence for benefit of drug-eluting stents with off-label use.
Büttner HJ; Neumann FJ
J Am Coll Cardiol; 2007 Nov; 50(21):2037-8. PubMed ID: 18021869
[No Abstract] [Full Text] [Related]
17. [Efficacy and safety of implantation of multiple drug-eluting stents].
Fu Q; Li ZL; Wu HC
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jan; 28(1):110-2. PubMed ID: 18227039
[TBL] [Abstract][Full Text] [Related]
18. Three years since the FDA advisory panel on drug-eluting stents: what have we learned about off-label use and stent thrombosis?
Naidu SS
J Invasive Cardiol; 2010 Jan; 22(1):20-1. PubMed ID: 20048394
[No Abstract] [Full Text] [Related]
19. Celecoxib and hypertension-insights from the effect of celecoxib on restenosis after coronary angioplasty with a taxus stent trial.
Bangalore S; Khianey S; Messerli FH
Am J Cardiol; 2008 Apr; 101(7):1068. PubMed ID: 18359335
[No Abstract] [Full Text] [Related]
20. Understanding the drug-eluting stent trials.
Coolong A; Kuntz RE
Am J Cardiol; 2007 Sep; 100(5A):17K-24K. PubMed ID: 17719349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
